The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zentalis Pharmaceuticals, Inc(NASDAQ:ZNTL) 
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidates are the ZN-c5, an oral selective estrogen receptor degrader that is in a Phase 1/2 clinical ...
Website: http://www.zentalis.com
Full Time Employees: 110
CEO: Anthony Y. Sun
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Zentalis Pharmaceuticals Days Payable Outstanding ttm (DPO)
Zentalis Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Zentalis Pharmaceuticals Op Cashflow Per Share ttm
Zentalis Pharmaceuticals Free Cashflow Per Share ttm
Zentalis Pharmaceuticals Cash Per Share ttm
Zentalis Pharmaceuticals (GAAP) P/E ratio ttm
Zentalis Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.